U.S. Health Care REITs Stock News

NYSE:EFC
NYSE:EFCMortgage REITs

Ellington Financial Q1 Revenue Surge Challenges Bearish Narratives On Earnings Sustainability

Ellington Financial (EFC) opened Q1 2026 with total revenue of US$151.9 million, basic EPS of US$0.78 and net income excluding extra items of US$95.5 million, setting a clear marker for how the year is starting. The company reported total revenue of US$75.3 million in Q4 2024, US$83.8 million in Q1 2025 and US$151.9 million in Q1 2026. Over the same first quarter snapshots, basic EPS moved from US$0.25 to US$0.35 and then to US$0.78, giving investors a view of how the top line and per share...
NYSE:TKR
NYSE:TKRMachinery

Timken (TKR) Q1 EPS Jump Tests Bullish Earnings Growth Narrative

Timken (TKR) opened 2026 with Q1 revenue of US$1.2 billion and basic EPS of US$1.41, setting the tone for how investors will read the rest of the year. Over the past few quarters, revenue has moved from US$1,073.6 million in Q4 2024 to US$1,140.3 million in Q1 2025 and now US$1,231.3 million in Q1 2026, while basic EPS has shifted from US$1.02 to US$1.12 and then to US$1.41 over the same points in time. This gives a clear view of the recent trend in the top and bottom lines. Against a...
NasdaqGS:KHC
NasdaqGS:KHCFood

Kraft Heinz (KHC) Q1 Profit Of US$798m Tests Longstanding Loss Narrative

Kraft Heinz (KHC) opened 2026 with Q1 revenue of US$6.0b, basic EPS of US$0.67 and net income of US$798m, setting the tone for how the rest of the year might shape up for shareholders watching profitability closely. The company has seen quarterly revenue move from US$6.6b in Q4 2024 to US$6.0b in Q1 2026, while basic EPS shifted from US$1.77 to US$0.67 over the same period, against a backdrop of trailing twelve month losses and only modest revenue growth. With analysts in the supplied data...
NasdaqGS:CABA
NasdaqGS:CABABiotechs

Cabaletta Bio (CABA) Is Up 34.2% After Early RESET-PV Data And US$150M Equity Raise

In early May 2026, Cabaletta Bio reported early RESET-PV trial data showing biologic and clinical activity for its rese-cel CAR T therapy in refractory pemphigus vulgaris patients treated at the lowest dose without chemotherapy preconditioning, alongside a completed US$150.00 million follow-on equity offering priced at US$2.90 per share. An interesting angle for investors is Cabaletta’s 10-year commercial supply agreement with Cellares, which aims to support automated, higher-throughput...
NYSE:TPL
NYSE:TPLOil and Gas

Texas Pacific Land Recasts Growth Story With Record Results And Data Center Deal

Texas Pacific Land (NYSE:TPL) reported record revenue and net income for the first quarter. The company agreed to a major land sale and water supply deal tied to a large scale data center project with a power plant developer. Texas Pacific Land appointed Peter Doyle, a leader at its largest shareholder, to the Board and its acquisitions committee. Texas Pacific Land, trading around $419.75, has had a mixed return profile, with a 40.9% gain year to date and a 181.8% return over 3 years,...
NYSE:OTIS
NYSE:OTISMachinery

Is It Time To Reconsider Otis Worldwide (OTIS) After A 20% One Year Share Price Slide?

If you have been wondering whether Otis Worldwide stock is attractively priced or just fairly valued at around US$76.71, the key is to look closely at what the current valuation actually reflects. Over the last week the stock is roughly flat with a 0.1% return, while the 30 day return of a 1.8% decline and the 1 year return of a 19.7% decline hint that sentiment around the long term story has shifted. Recent coverage has focused on how elevator and escalator demand ties into broader...
NYSE:TGLS
NYSE:TGLSBuilding

Undervalued Small Caps With Insider Buying Opportunities In May 2026

The United States market has shown robust performance recently, with a 3.2% increase over the last week and a remarkable 31% rise over the past year, while earnings are expected to grow by 16% annually. In this thriving environment, identifying small-cap stocks that may be undervalued and exhibit insider buying can present unique opportunities for investors seeking potential growth in their portfolios.
NasdaqCM:CXDO
NasdaqCM:CXDOIT

High Growth Tech Stocks to Watch in the US May 2026

The United States market has shown a robust performance, climbing 3.2% in the last week and up 31% over the past year, with earnings forecasted to grow by 16% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and scalability to capitalize on these favorable market conditions.